University of California San Francisco

News & Events

Displaying 49 - 54 of 54

Quan-Yang Duh Receives 2017 Paul Starr Award from American Thyroid Association

UCSF Endocrine Surgery
December 20, 2017
Quan-Yang Duh M.D., professor and chief of endocrine surgery at UCSF, and a nationally and internationally recognized leader in the field, is the recipient of the 2017 Paul Starr Award from the American Thyroid Association (ATA). The Paul Starr Award Lecture recognizes an outstanding contributor to clinical...
The Haile T Debas Academy of Medical Educators

UCSF Department of Surgery Faculty Honored with Excellence in Teaching Awards

UCSF Department of Surgery
October 02, 2017
The Haile T. Debas Academy of Medical Educators presented seven Department of Surgery faculty with the Excellence in Teaching Award for 2017 at a ceremony on September 11th at the UCSF School of Nursing, held in conjunction with the Academy's induction of new members. The Academy's Excellence in Teaching Awards...

Garry Shandling and the Disease You Didn’t Know About

UCSF Endocrine Surgery
April 07, 2016
James Fallows, national correspondent for The Atlantic, recently wrote about the death of comedian Garry Shandling, noting that he suffered from hyperparathyroidism, a condition that, if left untreated, can raise the risk of having a heart attack and other serious medical conditions. Fallows' piece was both...

Bilateral Adrenal Incidentalomas May Have Different Etiology Than Unilateral

UCSF Endocrine Surgery
October 01, 2015
MedicalResearch.com recently interviewed Quan-Yang Duh M.D. (pictured first), Chief of the Section of Endocrine Surgery, Division of General Surgery, at UCSF, on the differences in etiology of unilateral vs. bilateral incidentalomas. What we found in our study was that although the possible subclinical diseases...

Presence Of Gene Mutation Helps Guide Thyroid Cancer Treatment

UCSF Endocrine Surgery
September 06, 2007
"A specific gene mutation may be useful in predicting the level of aggression of thyroid cancer and help guide treatment options and follow-up care, according to new study findings. The mutation, called BRAF V600E, is a genetic alteration in the BRAF oncogene, a modified gene believed to cause cancer. ......."